Top Cancer Stocks in Australia
Browse the largest Australia companies in the world ranked by their Market Capitalization. Global Cancer Companies in Australia market cap is $4.93B.
15 Sept 2024, 11:13 UTC
Companies: 11
🇦🇺1 |  | $12.77 | 0.11% | 4.13B | 88.61% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺2 |  | $0.27 | -1.23% | 239.27M | 14.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺3 |  | $0.03 | 0.00% | 215.98M | -53.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺4 |  | $0.10 | -3.33% | 69.36M | 20.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺5 |  | $0.12 | -4.17% | 37.23M | 50.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺6 |  | $0.34 | -4.76% | 30.84M | -25.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺7 |  | $0.07 | -14.78% | 19.20M | 32.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺8 |  | $0.01 | 4.00% | 17.26M | 44.44% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇦🇺9 |  | $0.02 | 0.00% | 14.11M | 60.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺10 |  | $0.00 | 0.00% | 9.67M | -12.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺11 |  | $0.00 | 0.00% | 8.61M | -60.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
